Atlas Trials

Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Recifercept in Healthy Chinese Participants

Clinical trial NCT05061277 · WITHDRAWN

Trial details

NCT number
NCT05061277
Sponsor
Pfizer
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2023-10-25
Primary completion
2023-12-12
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.